Skip to content
Logo
  • Solutions
    Solutions
    • R&D Teams
    • Regulatory Teams
    • Commercial Teams
    • HEOR Teams
    • Cancer Centers and Oncologists
  • Products
    Products
    • Focus
    • Vantage
    • Vista
    • Clinicogenomics
    • Real-World Analytics
  • Services
    Services
    • Real-World Insights & Support
  • About Us
    About Us
    • Our Mission
    • Careers
  • Resources
    Resources
    • Research
    • Blog
    • News
    • Podcasts
    • Case Studies

    Reflections on ISPOR: Shifting data dynamics open new opportunities for RWD and RWE

    Read More

    How real-world ovarian cancer data will improve outcomes for women

    Read More
Contact Us

Day: September 11, 2020

The Lancet Rheumatology Publishes Additional Findings on Tocilizumab, Fueled by Real-World Data

A recent observational study using real world data shows promising results from using tocilizumab in patients with severe COVID-19. According to study co-author Shivam Mathura, “While these results need to be further validated through clinical trials, we are thrilled to provide early insights to those in the field as we continue to fight this pandemic.”

Logo
footer-background
Solutions
  • R&D Teams
  • Regulatory Teams
  • Commercial Teams
  • HEOR Teams
  • Oncology Providers
Products & Services
  • Focus
  • Vantage
  • Vista
  • Clinicogenomics
  • Real-World Analytics
  • Real-World Insights & Support
About Us
  • Our Mission
  • Careers
  • Become a Data Partner
Follow Us
  • LinkedIn
  • Real World Talk with COTA
  • Real World Talk with COTA
© 2025 COTA. All rights reserved.
  • Privacy Policy
  • Terms of Service
  • CCPA Privacy Notice